Cardiac complications in the intensive care unit.
Advances in the care of critically ill patients has been startling, especially in patients with acute coronary syndromes. With new therapies and procedures, however, have come new complications. On balance, our patients are better off, but the stakes are now higher and the complications more serious. The need for constant vigilance has never been greater.
Francis
G S
GS
George M. and Linda H. Kaufman Center for Heart Failure, Department of Cardiology, Cleveland Clinic Foundation, Ohio, USA.
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000209:etiology* / Q000628:therapy; D020117:Cisapride / Q000009:adverse effects; D004562:Electrocardiography; D004917:Erythromycin / Q000009:adverse effects; D005260:Female; D006220:Haloperidol / Q000009:adverse effects; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D015994:Incidence; D007362:Intensive Care Units / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D015996:Survival Rate; D015912:Thrombolytic Therapy / Q000009:adverse effects; D014481:United States / Q000453:epidemiology; D014883:Water-Electrolyte Imbalance / Q000150:complications
D000889:Anti-Arrhythmia Agents; D006634:Histamine H1 Antagonists; D004917:Erythromycin; D006220:Haloperidol; D020117:Cisapride